投資評等
最後更新日期：2024/4/26
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2011/6/29 | Wedbush | Underperform >> Outperform | $32 >> $37 |
| 2011/1/28 | Barclays Capital | Equal Weight >> Overweight | $31 >> $36 |
| 2011/1/13 | UBS | Neutral >> Buy | $30 >> $33 |
| 2009/11/5 | Cantor Fitzgerald | Hold >> Buy | |
| 2009/7/9 | Oppenheimer | Perform >> Outperform | 27 |
| 2005/6/3 | Raymond James | Mkt Perform->Strong Buy | 33 |
| 2005/4/5 | Goldman Sachs | In-Line->Outperform | |
| 2005/1/20 | Janney Mntgmy Scott | Hold->Buy | 32 |
| 2005/1/18 | Smith Barney Citigroup | Hold->Buy | 34 |
| 2005/1/18 | JP Morgan | Neutral->Overweight | |
| 2004/4/22 | Jefferies & Co | Underperform->Hold | $30 |
| 2003/11/6 | Davenport & Company | Sell -> Neutral | |
| 2003/11/6 | JP Morgan | Neutral -> Overweight | |
| 2003/8/14 | Janney Mntgmy Scott | Hold -> Buy | 25 |
| 2003/6/4 | Prudential | Hold -> Buy | 25 |
| 2003/3/28 | Thomas Weisel | Attractive -> Buy | |
| 2003/3/13 | JP Morgan | Underweight -> Neutral | |
| 2003/1/23 | Gerard Klauer Mattison | Outperform -> Buy | 17 |
| 2003/1/23 | Kaufman Bros | Hold -> Buy | 18 |
| 2003/1/13 | Goldman Sachs | Underperform -> Rn-Line | |
| 2003/1/10 | Raymond James | Mk -> Rerform -> Outperform | 14 |
| 2002/11/21 | Thomas Weisel | Mk -> Rerform -> Attractive | |
| 2002/11/7 | Janney Mntgmy Scott | Sell -> Hold | |
| 2002/11/7 | Raymond James | Mk -> Rerform -> Outperform | 12 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2015/11/12 | Barclays | Overweight >> Equal Weight | 60 |
| 2013/3/14 | Oppenheimer | Outperform >> Perform | |
| 2012/5/2 | Standpoint Research | Buy >> Hold | |
| 2009/1/16 | Wedbush Morgan | Strong Buy Buy | |
| 2006/9/28 | Morgan Stanley | Overweight Equal-weight | |
| 2004/12/13 | Janney Mntgmy Scott | Buy->Hold | |
| 2003/12/16 | Jefferies & Co | Hold->Underperform | |
| 2003/12/16 | Prudential | Overweight->Neutral | $30 |
| 2003/11/13 | Raymond James | Strong Buy -> Outperform | |
| 2003/7/24 | JP Morgan | Overweight -> Neutral | |
| 2002/7/25 | Goldman Sachs | Recomm List -> Mkt Perform | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2010/7/16 | Barclays Capital | Equal Weight | 33 |
| 2007/12/13 | Kaufman Bros | Hold | 37 |
| 2007/7/2 | UBS | Neutral | 44 |
| 2006/6/16 | Robert W. Baird | Outperform | 42 |
| 2005/10/20 | Lehman Brothers | Overweight | 1900/2/1 |
| 2004/11/16 | CSFB | Neutral | 26 |
| 2004/4/12 | Morgan Stanley | Overweight | 40 |
| 2004/4/8 | Harris Nesbitt Gerard | Outperform | 34 |
| 2003/8/26 | Wedbush Morgan | Buy | 31 |
| 2003/7/16 | Jefferies & Co | Hold | |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 查無資料 | | | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2011/2/24 | Stifel Nicolaus | Buy | $33 >> $35 |
| 2010/11/4 | RBC Capital Mkts | Outperform | $38 >> $36 |
| 2010/11/4 | FBR Capital | Mkt Perform | $33 >> $30 |
| 2010/7/22 | Wedbush | Neutral | $32 >> $30 |
| 2010/1/21 | UBS | Neutral | $27 >> $29 |
| 2010/1/21 | Kaufman Bros | Hold | $28 >> $32 |
| 2010/1/21 | Wedbush Morgan | Neutral | $28 >> $30 |
| 2010/1/21 | FBR Capital | Mkt Perform | $26 >> $30 |
| 2009/12/4 | Standpoint Research | Buy | $30 >> $34 |
| 2009/9/23 | Oppenheimer | Outperform | $27 >> $32 |